Common Names: goldenseal
This study analyzed botanical dietary supplements using NMR and mass spectrometry to assess product quality and authenticity. Outliers were identified, and known constituents helped determine product authenticity. NMR and MS data provided similar and complementary results.
Researchers studied the effects of Hydrastis Canadensis (Goldenseal) on hormone-independent breast cancer using computational techniques. Canadaline and Riboflavin were found to effectively interact with target proteins, making Hydrastis Canadensis a potential treatment for hormone-independent and some hormone-dependent breast cancers.
This study notes that patients can suffer harm from using conventional and complementary medicines together. However, this harm can be avoided. The researchers emphasize the importance of healthcare professionals educating patients about safe practices when using CMs alongside conventional medicine.
This study explored the potential neuroprotective effects of berberine (BBR) against Alzheimer's disease (AD) in vitro. Researchers established an apoptotic model in HT22 cells induced by Aβ and treated them with BBR. Results showed that BBR improved cell viability, inhibited Aβ-induced apoptosis and intracellular ROS levels, and intensified the activity of Nrf2/HO-1 antioxidants in HT22 cells. It also restrained the mitochondrial pathway of cellular apoptosis by decreasing the rate of p-p65/p65, cytochrome C, and cleaved caspase-3. This led the researchers to conclude that BBR provides neuroprotectiveness by alleviating oxidative stress and inhibiting the mitochondrial pathway of cellular apoptosis.